Cuttlefish to Clinic: translating blue skies (blue seas) research into medical innovation
Dr Shelby Temple
In-person (Psychology Common Room, Social Sciences Complex, Priory Road, BS8 1TU) and online via Zoom.
Abstract
Cuttlefish, octopus and squid don’t see colour and instead they see the polarization of light. Dr Temple developed new ways of testing polarization sensitivity in cephalopods and in the process discovered that he had inadvertently developed a new way for measuring a key risk factor for the leading cause of incurable blindness in humans (age-related macular degeneration). Dr Temple patented the technique and spun out a company (azulOptics Ltd) to translate the idea into an ophthalmic device that is now used by optometrists and ophthalmologists in over a dozen countries. Come and learn about the voyage of discovery, translation, clinical trials, product development, marketing, business and how this new tool is helping people protect their eyes.
For further information on Dr Temple's research, take a look at his Bristol profile.
Contact information
For any queries, please contact bvi-enquiries@bristol.ac.uk
